Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: A systematic review

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 6, 2003, Pages 1339-1350

  Thomas, Claudia ^a   Stevenson, Mark ^a   Riley, Thomas ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Medical Research   (Australia)

Author keywords

Clostridium Difficile; Systematic review

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTACID AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; ERYTHROMYCIN; IMMUNOSUPPRESSIVE AGENT; LINCOMYCIN; METRONIDAZOLE; PENICILLIN G; PYRIMETHAMINE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; CLINICAL STUDY; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; EXPERIMENTAL DESIGN; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION RISK; META ANALYSIS; NONHUMAN; PATHOGENICITY; RELIABILITY; RETROSPECTIVE STUDY; REVIEW; SAMPLE SIZE; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS;

EID: 0038648403     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg254     Document Type: Review

References (78)

1. Riley, T. V. (1994). The epidemiology of Clostridium difficile-associated diarrhoea. Reviews in Medical Microbiology 5, 117-22.
2. Kelly, C. & LaMont, J. (1998). Clostridium difficile infection. Annual Review of Medicine 49, 375-90.
3. Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L. & Onderdonk, A. B. (1978). Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. New England Journal of Medicine 298, 531-4.
4. Larson, H. E., Price, A. B. & Honour, P. (1978). Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet i, 1063-6.
5. Cartmill, T. D. I., Panigrahi, H., Worsley, M. A., McCann, D. C., Nice, C. N. & Keith, E. (1994). Management and control of a large outbreak of diarrhoea due to Clostridium difficile. Journal of Hospital Infection 27, 1-15.
6. Frost, F., Craun, G. F. & Calderon, R. L. (1998). Increasing hospitalisation and death possibly due to Clostridium difficile diarrheal disease. Emerging Infectious Diseases 4, 619-25.
7. Wilcox, M. H. & Smyth, E. T. M. (1998). Incidence and impact of Clostridium difficile infection in the UK, 1993-1996. Journal of Hospital Infection 39, 181-7.
8. Djuretic, T., Wall, P. G. & Brazier, J. S. (1999). Clostridium difficile: an update on its epidemiology and role in hospital outbreaks in England and Wales. Journal of Hospital Infection 41, 213-8.
9. Johnson, S., Samore, M. H., Farrow, K. A., Killgore, G. E., Tenover, F. C., Lyras, D. et al. (1999). Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. New England Journal of Medicine 341, 1645-51.
10. Johnson, S. & Gerding, D. N. (1998). Clostridium difficile-associated diarrhea. Clinical Infectious Diseases 26, 1027-34.
11. Bignardi, G. E. (1998). Risk factors for Clostridium difficile infection. Journal of Hospital Infection 40, 1-15.
12. Egger, M., Schneider, M. & Davey Smith, G. (1998). Spurious precision? Meta-analysis of observational studies. British Medical Journal 316, 140-4.
13. Bliss, D. Z., Johnson, S., Savik, K., Clabots, C. R., Willard, K. & Gerding, D. N. (1998). Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhoea in hospitalised patients receiving tube feeding. Annals of Internal Medicine 129, 1012-9.
14. Rabasa, M., Aguado, J. M., Lizasoain, M., Pedraza, M. A., Arribas, P., Lumbreras, C. et al. (1993). Yield of detection of Clostridium difficile toxin versus stool culture in the study of nosocomial diarrhea. Enfermedades Infecciosas y Microbiologia Clinica 11, 479-81.
15. Tacconelli, E., Leone, F., Mazzella, P. & Tumbarello, M. (1994). Clostridium difficile associated diarrhea: Two years of observation in a University Hospital. Igiene Moderna 102, 95-104.
16. Ramos, A., Gazapo, T., Murillas, J., Portero, J. L., Valle, A. & Martin, F. (1998). Outbreak of nosocomial diarrhea by Clostridium difficile in a department of internal medicine. Enfermedades Infecciosas y Microbiologia Clinica 16, 66-9.
17. Selva O'Callaghan, A., Yuste, M., Armadans, L., Almirante Gragera, B., San Jose Laporte, A. & Vilardell Tarres, M. (2000). Factors for, Clostridium difficile-associated diarrhoea in elderly patients. A case-control study. Medicina Clinica 115, 499-500.
18. Thompson, C. M., Jr, Gilligan, P. H., Fisher, M. C. & Long, S. S. (1983). Clostridium difficile cytotoxin in a pediatric population. American Journal of Diseases of Children 137, 271-4.
19. Zimmerman, R. K. (1991). Risk factors for Clostridium difficile cytotoxin-positive diarrhoea after control for horizontal transmission. Infection Control and Hospital Epidemiology 12, 96-100.
20. Jensen, G. L., Bross, J. E., Bourbeau, P. P., Naumovitz, D. W., Streater, M. & Gianferante, L. E. (1994). Risk factors for Clostridium difficile stool cytotoxin b among critically ill patients: role of sucralfate. Journal of Infectious Diseases 170, 227-30.
21. Cooper, G. S., Lederman, M. M. & Salata, R. A. (1996). A predictive model to identify Clostridium difficile toxin in hospitalized patients with diarrhea. American Journal of Gastroenterology 91, 80-4.
22. Katz, D. A., Lynch, M. E. & Littenberg, B. (1996). Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. American Journal of Medicine 100, 487-95.
23. Watanakunakorn, P. W., Watanakunakorn, C. & Hazy, J. (1996). Risk factors associated with Clostridium difficile, diarrhea in hospitalized adult patients: a case-control study-sucralfate ingestion is not a negative risk factor. Infection Control and Hospital Epidemiology 17, 232-5.
24. Burgner, D., Siarakas, S., Eagles, G., McCarthy, A., Bradbury, R. & Stevens, M. (1997). A prospective study of Clostridiurn difficile infection and colonization in pediatric oncology patients. Pediatric Infectious Disease Journal 16, 1131-4.
25. Lai, K. K., Melvin, Z. S., Menard, M. J., Kotilainen, H. R. & Baker, S. (1997). Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control. Infection Control and Hospital Epidemiology 18, 628-32.
26. Climo, M. W., Israel, D. S., Wong, E. S., Williams, D., Coudron, P. & Markowitz, S. M. (1998). Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Annals of Internal Medicine 128, 989-95.
27. Hornbuckle, K., Chak, A., Lazarus, H. M., Cooper, G. S., Kutteh, L. A., Gucalp, R. et al. (1998). Determination and validation of a predictive model for Clostridium difficile diarrhea in hospitalized oncology patients. Annals of Oncology 9, 307-11.
28. Guyot, A., Rawlins, M. D. & Barrett, S. P. (2000). Clarithromycin appears to be linked with Clostridium difficile-associated diarrhoea in the elderly. Journal of Antimicrobial Chemotherapy 46, 642-3.
29. Shah, S., Lewis, A., Leopold, D., Dunstan, F. & Woodhouse, K. (2000). Gastric acid suppression does not promote clostridial diarrhoea in the elderly. QJM: Monthly Journal of the Association of Physicians 93, 175-81.
30. Mody, L. R., Smith, S. M. & Dever, L. L. (2001). Clostridium difficile-associated diarrhea in a VA medical center: clustering of cases, association with antibiotic usage, and impact on HIV-infected patients. Infection Control and Hospital Epidemiology 22, 42-5.
31. Cheng, S.-H., Lu, J.-J., Young, T.-G., Perng, C.-L. & Chi, W.-M. (1997). Clostridium difficile-associated diseases: comparison of symptomatic infection versus carriage on the basis of risk factors, toxin production and genotyping results. Clinical Infectious Diseases 25, 157-8.
32. Crabtree, T. D., Pelletier, S. J., Gleason, T. G., Pruett, T. L. & Sawyer, R. G. (1999). Clinical characteristics and antibiotic utilization in surgical patients with Clostridium difficile-associated diarrhea. American Surgeon 65, 507-11.
33. Keighley, M. R., Burdon, D. W., Alexander-Williams, J., Shinagawa, N., Arabi, Y., Thompson, H. et al. (1978). Diarrhoea and pseudomembranous colitis after gastrointestinal operations. A prospective study. Lancet ii, 1165-7.
34. Gerding, D. N., Olson, M. M., Peterson, L. R., Teasley, D. G., Gebhard, R. L., Schwartz, M. L. et al. (1986). Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Archives of Internal Medicine 146, 95-100.
35. Grube, B. J., Heimbach, D. M. & Marvin, J. A. (1987). Clostridium difficile diarrhea in critically ill burned patients. Archives of Surgery 122, 655-61.
36. Johnson, S., Clabots, C. R., Linn, F. V., Olson, M. M., Peterson, L. R. & Gerding, D. N. (1990). Nosocomial Clostridium difficile colonisation and disease. Lancet 336, 97-100.
37. Cartmill, T. D., Shrimpton, S. B., Panigrahi, H., Khanna, V., Brown, R. & Poxton, I. R. (1992). Nosocomial diarrhoea due to a single strain of Clostridium difficile: a prolonged outbreak in elderly patients. Age and Ageing 21, 245-9.
38. Talon, D., Bailly, P., Delmée, M., Thouverez, M., Mulin, B., Iehl-Robert, M. et al. (1995). Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients. European Journal of Clinical Microbiology and Infectious Diseases 14, 987-93.
39. Tumbarello, M., Tacconelli, E., Leone, F., Cauda, R. & Ortona, L. (1995). Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study. European Journal of Gastroenterology and Hepatology 7, 259-63.
40. Thamlikitkul, V., Danpakdi, K. & Chokloikaew, S. (1996). Incidence of diarrhea and Clostridium difficile toxin in stools from hospitalized patients receiving clindamycin, beta-lactams, or non-antibiotic medications. Journal of Clinical Gastroenterology 22, 161-3.
41. Kent, K. C., Rubin, M. S., Wroblewski, L., Hanff, P. A. & Silen, W. (1998). The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients. Annals of Surgery 227, 296-301.
42. Schwaber, M. J., Simhon, A., Block, C., Roval, V., Ferderber, N. & Shapiro, M. (2000). Factors associated with nosocomial diarrhea and Clostridium difficile-associated disease on the adult wards of an urban tertiary care hospital. European Journal of Clinical Microbiology and Infectious Diseases 19, 9-15.
43. Pierce, P. F., Jr, Wilson, R., Silva, J., Jr, Garagusi, V. F., Rifkin, G. D., Fekety, R. et al. (1982). Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. Journal of Infectious Diseases 145, 269-74.
44. Thibault, A., Miller, M. M. & Gaese, C. (1991). Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infection Control and Hospital Epidemiology 12, 345-8.
45. Nelson, D. E., Auerbach, S. B., Baltch, A. L., Desjardin, E., Beck-Sague, C., Rheal, C. et al. (1994). Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins. Infection Control and Hospital Epidemiology 15, 88-94.
46. Pear, S. M., Williamson, T. H., Bettin, K. M., Gerding, D. N. & Galgiani, J. N. (1994). Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Annals of Internal Medicine 120, 272-7.
47. Kreisel, D., Savel, T. G., Silver, A. L. & Cunningham, J. D. (1995). Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Archives of Surgery 130, 989-93.
48. Barbut, F., Meynard, J. L., Guiguet, M., Avesani, V., Bochet, M. V., Meyohas, M. C. et al. (1997). Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors. Journal of Acquired Immune Deficiency Syndromes 16, 176-81.
49. Yip, C., Loeb, M., Salama, S., Moss, L. & Olde, J. (2001). Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea. Infection Control and Hospital Epidemiology 22, 572-5.
50. Ferroni, A., Merckx, J., Ancelle, T., Pron, B., Abachin, E., Barbut, F. et al. (1997). Nosocomial outbreak of Clostridium difficile diarrhea in a pediatric service. European Journal of Clinical Microbiology and Infectious Diseases 16, 928-33.
51. Bilgrami, S., Feingold, J. M., Dorsky, D., Edwards, R. L., Bona, R. D., Khan, A. M. et al. (1999). Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation 23, 1039-42.
52. Chakrabarti, S., Lees, A., Jones, S. G. & Milligan, D. W. (2000). Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplantation 26, 871-6.
53. McFarland, L. V., Surawicz, C. M. & Stamm, W. E. (1990). Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. Journal of Infectious Diseases 162, 678-84.
54. Hutin, Y., Molina, J. M., Casin, I., Daix, V., Sednaoui, P., Welker, Y. et al. (1993). Risk factors for Clostridium difficile-associated diarrhoea in HIV-infected patients. AIDS 7, 1441-7.
55. Brazier, J. S. & Duerden, B. I. (1998). Guidelines for optimal surveillance of Clostridium difficile infection in hospitals. Communicable Disease and Public Health 1, 229-30.
56. Nath, S. K., Salama, S., Persaud, D., Thornley, J. H., Smith, I., Foster, G. et al. (1994). Drug risk factors associated with a sustained outbreak of Clostridium difficile diarrhea in a teaching hospital. Canadian Journal of Infectious Diseases 5, 270-5.
57. Barthram, J. D., Dunstan, F. D. J., Hill, D., Hosein, I. K. & Pippen, C. A. R. (1995). Clostridium difficile: The association between antibiotic therapy and the incidence of infection in the elderly. Pharmaceutical Journal 255, 276-8.
58. Impallomeni, M., Galletly, N. P., Wort, S. J., Starr, J. M. & Rogers, T. R. (1995). Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime. British Medical Journal 311, 1345-6.
59. Halim, H. A., Peterson, G. M., Friesen, W. T. & Ott, A. K. (1997). Case-controlled review of Clostridium difficile-associated diarrhoea in Southern Tasmania. Journal of Clinical Pharmacy and Therapeutics 22, 391-7.
60. MacGowan, A. P., Feeney, R., Brown, I., McCulloch, S. Y., Reeves, D. S. & Lovering, A. M. (1997). Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea. Journal of Antimicrobial Chemotherapy 39, 537-41.
61. Harbarth, S., Samore, M. H. & Carmeli, Y. (2001). Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea. Journal of Hospital Infection 48, 93-7.
62. Gorecki, P., Schein, M., Rucinski, J. C. & Wise, L. (1999). Antibiotic administration in patients undergoing common surgical procedures in a community teaching hospital: the chaos continues. World Journal of Surgery 23, 429-32,
63. Chang, V. T. & Nelson, K. (2000). The role of physical proximity in nosocomial diarrhea. Clinical Infectious Diseases 31, 717-22.
64. Brown, E., Talbot, G. H., Axelrod, P., Provencher, M. & Hoegg, C. (1990). Risk factors for Clostridium difficile toxin-associated diarrhea. Infection Control and Hospital Epidemiology 11, 283-90.
65. Aziz, E. E., Ayis, S., Gould, F. K. & Rawlins, M. D. (2001). Risk factors for the development of Clostridium difficile toxin-associated diarrhoea: A pilot study. Pharmacoepidemiology and Drug Safety 10, 303-8.
66. Rothman, K. J. & Greenland, S. (1998). Cohort studies. In Modern Epidemiology, 2nd edn (Rothman, K. J. & Greenland, S., Eds), pp. 79-91. Lippincott-Raven, Philadelphia, PA, USA.
67. Wilcox, M. (2001). Clarithromycin and risk of Clostridium difficile-associated diarrhoea. Journal of Antimicrobial Chemotherapy 47, 358-9.
68. Guyot, A. & Barrett, S. P. (2001). What is an appropriate control group to identify risk factors for Clostridium difficile-associated diarrhoea? Journal of Antimicrobial Chemotherapy 48, 747-8.
69. Brazier, J. S. (1993). Role of the laboratory in investigations of Clostridium difficile diarrhea. Clinical Infectious Diseases 16, S228-33.
70. Freeman, J. & Wilcox, M. H. (2003). The effects of storage conditions on viability of Clostridium, difficile vegetative cells and spores and toxin activity in human faeces. Journal of Clinical Pathology 56, 126-8.
71. Lashner, B. A., Todorczuk, J., Sahm, D. F. & Hanauer, S. B. (1986). Clostridium difficile culture-positive toxin-negative diarrhea. American Journal of Gastroenterology 81, 940-3.
72. Riley, T. V., O'Neill, G. L., Bowman, R. A. & Golledge, C. L. (1994). Clostridium difficile-associated diarrhoea: epidemiological data from Western Australia. Epidemiology and Infection 113, 13-20.
73. Martirosian, G., van Belkum, A., Pituch, H. Obuch-Woszczatynski, P. & Meisel-Mikolajczyk, F. (2000). Are rapid immunoassays for in vivo detection of toxin A sufficient for diagnostic purposes of Clostridium difficile-associated diseases? Anaerobe 6, 15-9.
74. Brazier, J. S., Stubbs, S. L. & Duerden, B. I. (1999). Prevalence of toxin A negative/B positive Clostridium difficile strains. Journal of Hospital Infection 42, 248-9.
75. Doern, G. V., Coughlin, R. T. & Wu, L. (1992). Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays. Journal of Clinical Microbiology 30, 2042-6.
76. Barbut, F., Kajzer, C., Planas, N. & Petit, J.-C. (1993). Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhoea. Journal of Clinical Microbiology 31, 963-7.
77. Merz, C. S., Kramer, C., Forman, M., Gluck, L., Mills, K., Senft, K. et al. (1994). Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens. Journal of Clinical Microbiology 32, 1142-7.
78. Delmée, M. (2001). Laboratory diagnosis of Clostridium difficile disease. Clinical Microbiology and Infection 7, 411-6.